To view this email as a web page, click here.

 
Teleglaucoma lets patients be more engaged in care
New technology for taking the evaluation, diagnosis, and management of glaucoma out of the clinic and directly to the patient is influencing not only community outreach efforts but the feasibility of using teleglaucoma tools in the home.
Read on
ADVERTISEMENT
 
Safety key for intracamerally injected mydriatic agents in cataract surgery
The side effect that may go along with a drug is always a concern, regardless of the age or general health of a patient. However, those concerns are amplified in older populations, particularly those who are at increased risk of cardiovascular events.
Find out
ADVERTISEMENT
 
Understand the expanding role of IPL in dry eye disease
image description here The latest installment of our “Let’s Chat” blog series features Richard Adler, MD, as he explains how intense pulsed light (IPL) treats the fundamental root cause of dry eye, not just the downstream consequences.

Learn more
 
ADVERTISEMENT
Unleash the Power of your Optical.
We’ll help you reach the untapped potential within your dispensary. Imagine if your optical performed as well as your practice? Now it can. Vision, the largest optical dispensary management and consulting firm in the country can help! www.visassoc.com. AAO Booth #5048
 
RELATED ARTICLES
 
These 3 things are part of a cataract surgeon’s signature
10 effective habits of a cataract surgeon
Quieting the neuropathic components of ocular pain
Pearls to manage cataract surgery on hypotonous eyes
Pushing the boundaries with monofocal toric IOL
Surgeons eye letter-perfect outcomes with new extended depth of focus IOL
 
ADVERTISEMENT
You're invited to recognize excellence
RSVP now to join Ophthalmology Times in recognizing winners of the 2019 Resident Writers Award Program. This unique opportunity promotes excellence in anterior segment education, acknowledging the best in case identification and written presentation skills. Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.